In 2025, there was continuity and change in U.S. policy that impacted both Chinese and APAC investment into the U.S., and U.S. investment into China. For the investment community, a key question has become how to navigate the U.S. regulatory environment while maximizing business opportunities in the two jurisdictions. A U.S. corporate and regulatory lawyer at a U.S. firm helps make sense of the developments
SAMR delegates certain antitrust reviews to local market regulators. Chinese companies may extend offshore loans to overseas companies with shareholding relationships only. Use of overseas registered product barcodes require record filing.
PBOC has introduced rules to facilitate the offshore funding of renminbi / CLP Reference: 3610/26.02.24 ; Issued: 2026-02-24 ; Effective: 2026-02-24
CSRC consolidates identical or similar disclosure items in regular reports of securities investment funds / CLP Reference: 2330/26.03.13 ; Promulgated: 2026-03-13 ; Effective: 2026-05-01
Chinese financial regulator considers allowing major investors to hold stakes in additional banks to boost capital. | Brazilian preliminary injunction bans Geely from patent dispute-related activities. | Envisioned U.S. national AI framework could put pressure on Chinese AI services.
Daisy Duan, Sara Shi and Chenlu Wang of King & Wood explain China’s implementation of the Common Reporting Standard for tax information and explore the implications for Chinese taxpayers with overseas income
Jianwei (Jerry) Fang, Haoyi Sun, Junda He and Yi Dai of Zhong Lun Law Firm examine and discuss the key types, trends, and observations in U.S. litigation involving Chinese enterprises in 2025
Xiangxiang Ma of Anjie Broad Law Firm explores the key legal and regulatory developments affecting China’s vital healthcare sector in 2025
In 2025, China's antitrust landscape continued to evolve with greater sophistication across legislation, merger control, administrative enforcement, and litigation. Here, Huang Wei, Zhu Fan, Gao Chang and Chen Kexin of Tian Yuan Law Firm give an overview of the major developments and key takeaways
China increases scrutiny of Manus-Meta Deal | Recent Chinese notice raises concerns over red-chip company ban in Hong Kong listings | Chinese court rejects circular reuse defense in luxury handbag repurposing dispute
